Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Betamethasone dipropionate - Oticara

Next Previous
Drug Profile

Betamethasone dipropionate - Oticara

Latest Information Update: 27 Feb 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Oticara
  • Class Anti-inflammatories; Antiallergics; Antipsoriatics; Fluorinated steroids; Glucocorticoids; Small molecules
  • Mechanism of Action Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Rhinosinusitis; Sinusitis

Most Recent Events

  • 27 Feb 2026 Phase-II clinical trials in Sinusitis in Australia (Intranasal), prior to February 2026 (Oticara pipeline, February 2026)
  • 13 Oct 2025 Efficacy and adverse events data from a phase II trial in Rhinosinusitis released by Oticara
  • 08 Oct 2025 Oticara has patent protection for "Method for treating nasal, sinonasal, and nasopharyngeal tissue infection and/or inflammation" in Australia, China, Japan, the US and other countries worldwide and has patent pending in Canada, South Korea and the European Union

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top